HARKE GROUP придбала шведську Vendico Group

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…

We have made some changes that we would like to inform you about. PJSC “FITOFARM” received an extension of the license to carry out economic activities for the production of…